Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 9/2006

01-09-2006 | Research Articles

Significance of the immunohistochemical detection of lymph node micrometastases in Stage II Colorectal Carcinoma

Authors: José A. García-Sáenz, María C. Sáenz, Lucía González, Pedro Pérez-Segura, Javier Puente, Sara López-Tarruella, Javier Sastre, Antonio Casado, José G. López-Asenjo, Eduardo Díaz-Rubio

Published in: Clinical and Translational Oncology | Issue 9/2006

Login to get access
Metadata
Title
Significance of the immunohistochemical detection of lymph node micrometastases in Stage II Colorectal Carcinoma
Authors
José A. García-Sáenz
María C. Sáenz
Lucía González
Pedro Pérez-Segura
Javier Puente
Sara López-Tarruella
Javier Sastre
Antonio Casado
José G. López-Asenjo
Eduardo Díaz-Rubio
Publication date
01-09-2006
Publisher
Springer-Verlag
Published in
Clinical and Translational Oncology / Issue 9/2006
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-006-0038-4

Other articles of this Issue 9/2006

Clinical and Translational Oncology 9/2006 Go to the issue

Educational Series

Somatic stem cells and the origin of cancer

Case Reports

Recurrent pericardial effusion as initial manifestation of primary diffuse pericardial malignant mesothelioma

Research Articles

Conservative treatment for infiltrating breast cancer: Ten years follow-up experience

Editorial

The procedures for assessing oncological research in Spain

Research Articles

Quality of life assessment through the EORTC questionnaires of colorectal cancer patients in advanced disease stages

Research Articles

Testicular neoplasms. Evaluation of the experience during 25 years in a military hospital
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits